NCT05285735View on ClinicalTrials.gov

Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants

RecruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

June 8, 2029

Study Completion Date

July 1, 2029

Conditions
PregnancyMalaria
Trial Locations (1)

08854

RECRUITING

4C Pharma Solutions, Piscataway

Sponsors

Lead Sponsor

Amivas Inc.
All Listed Sponsors
lead

Amivas Inc.

INDUSTRY

NCT05285735 - Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants | Biotech Hunter | Biotech Hunter